JP2024505564A5 - - Google Patents
Info
- Publication number
- JP2024505564A5 JP2024505564A5 JP2023546449A JP2023546449A JP2024505564A5 JP 2024505564 A5 JP2024505564 A5 JP 2024505564A5 JP 2023546449 A JP2023546449 A JP 2023546449A JP 2023546449 A JP2023546449 A JP 2023546449A JP 2024505564 A5 JP2024505564 A5 JP 2024505564A5
- Authority
- JP
- Japan
- Prior art keywords
- ifn
- modified immune
- immune cell
- cell according
- cytokine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163144860P | 2021-02-02 | 2021-02-02 | |
| US63/144,860 | 2021-02-02 | ||
| PCT/US2022/014936 WO2022169870A1 (en) | 2021-02-02 | 2022-02-02 | Self-polarizing immune cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024505564A JP2024505564A (ja) | 2024-02-06 |
| JP2024505564A5 true JP2024505564A5 (enExample) | 2025-01-27 |
Family
ID=82741763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023546449A Pending JP2024505564A (ja) | 2021-02-02 | 2022-02-02 | 自己分極化免疫細胞 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240299543A1 (enExample) |
| EP (1) | EP4288072A4 (enExample) |
| JP (1) | JP2024505564A (enExample) |
| KR (1) | KR20230141841A (enExample) |
| CN (1) | CN116867501A (enExample) |
| AU (1) | AU2022215561A1 (enExample) |
| CA (1) | CA3206885A1 (enExample) |
| IL (1) | IL304559A (enExample) |
| MX (1) | MX2023008935A (enExample) |
| WO (1) | WO2022169870A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240376229A1 (en) * | 2023-05-12 | 2024-11-14 | Regeneron Pharmaceuticals, Inc. | Interferon receptor antagonists and uses thereof |
| CN121532418A (zh) * | 2023-07-17 | 2026-02-13 | 南京传奇生物科技有限公司 | 融合蛋白及其使用方法 |
| WO2025235801A1 (en) | 2024-05-08 | 2025-11-13 | City Of Hope | Antibodies targeted to osteopontin and uses thereof for reducing resistance of solid tumors immune cell therapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020010597A2 (pt) * | 2017-12-08 | 2020-10-27 | Fate Therapeutics, Inc. | imunoterapias com o uso de células efetoras derivadas de ipsc intensificadas |
| EP3561053A1 (en) * | 2018-04-26 | 2019-10-30 | Baylor College of Medicine | Immune effector cells and molecular adaptors with an antigen cytokine complex for effective cancer immunotherapy |
| CN113508178A (zh) * | 2019-02-01 | 2021-10-15 | 西雅图儿童医院（Dba西雅图儿童研究所） | 用于调节经工程化的基因的表达的微环境传感器 |
| CN114127297A (zh) * | 2019-03-26 | 2022-03-01 | 加维什-加利里生物应用有限公司 | 遗传重编程的表达car的treg |
-
2022
- 2022-02-02 CA CA3206885A patent/CA3206885A1/en active Pending
- 2022-02-02 US US18/275,258 patent/US20240299543A1/en active Pending
- 2022-02-02 WO PCT/US2022/014936 patent/WO2022169870A1/en not_active Ceased
- 2022-02-02 EP EP22750324.0A patent/EP4288072A4/en active Pending
- 2022-02-02 AU AU2022215561A patent/AU2022215561A1/en active Pending
- 2022-02-02 KR KR1020237029853A patent/KR20230141841A/ko active Pending
- 2022-02-02 CN CN202280012980.XA patent/CN116867501A/zh active Pending
- 2022-02-02 JP JP2023546449A patent/JP2024505564A/ja active Pending
- 2022-02-02 MX MX2023008935A patent/MX2023008935A/es unknown
-
2023
- 2023-07-18 IL IL304559A patent/IL304559A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cameron et al. | Cytokines, chemokines and their receptors | |
| US11339198B2 (en) | Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells | |
| Morán et al. | Cytokines, chemokines and growth factors | |
| Domingo-Gonzalez et al. | Cytokines and chemokines in Mycobacterium tuberculosis infection | |
| Fischer et al. | A bioactive designer cytokine for human hematopoietic progenitor cell expansion | |
| JP6388408B2 (ja) | アゴニストおよびアンタゴニストとしての循環置換により修飾されるリガンド | |
| US6617135B1 (en) | Multiple cytokine protein complexes | |
| Kishimoto | Interleukin-6 and its receptor in autoimmunity | |
| CN101484472B (zh) | 改善的sgp130Fc二聚体 | |
| JP2021527700A5 (enExample) | ||
| US6423500B1 (en) | Mammalian receptors for interleukin-10 | |
| US6313272B1 (en) | DNA encoding high affinity interleukin-4 muteins | |
| Shibuya et al. | Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genes | |
| Cabrillat et al. | High affinity binding of human interleukin 4 to cell lines | |
| WO2022165443A1 (en) | Chimeric molecules comprising an il-10 or tgf-beta agonist polypeptide | |
| US7268223B2 (en) | Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof | |
| JP2009529027A (ja) | ヒトインターフェロンガンマ（ＩＦＮγ）変異体 | |
| CA3180251A1 (en) | Cytokine conjugates | |
| CN112839964A (zh) | 包含融合蛋白的药物组合物及其用途 | |
| JP2024515577A5 (enExample) | ||
| AU2013203171B2 (en) | Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells | |
| Lewko et al. | Cytokines | |
| Matthews | Cytokines, cytokine antagonists, and growth factors for treating infections | |
| Brakenhoff et al. | Identification of residues in the putative 5th helical region of human interleukin‐6, important for activation of the IL‐6 signal transducer, gp130 | |
| Meager et al. | Interleukins |